Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Alto Neuroscience logo

Alto Neuroscience

Recent Finacing

Equity

Recent Raise

$50M

Alto Neuroscience is a clinical-stage precision psychiatry biotech developing digital biomarker-guided drugs for depression and other neuropsychiatric disorders.

California, United States
51-100
Publicly Traded
altoneuroscience.com
PitchBook

Highlights

Focus Areas

Artificial Intelligence (AI)
Biopharma
Biotechnology
Neuroscience
Precision Medicine

Recent Investors

What If Ventures logo
Windham Venture Partners logo
Alpha Wave Ventures logo
Lightswitch Capital logo
Apeiron Investment Group logo
K2 HealthVentures logo
Perceptive Advisors logo
Commodore Capital logo
V
Vivo Capital logo
Alexandria Venture Investments logo
Eli Lilly and Company logo

Financials

$164.6M

Valuation as of 10/20/2025

$230M

Total Raised

5

Funding rounds

24

Investors


Team

Upgrade to view the team

See the team members at Alto Neuroscience.